-
2
-
-
0242456119
-
Treatment of non-small-cell lung cancer: State of the art and development of new biologic agents
-
Gridelli C, Rossi A, Maione P. Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents. Oncogene 2003; 22:6629-6638.
-
(2003)
Oncogene
, vol.22
, pp. 6629-6638
-
-
Gridelli, C.1
Rossi, A.2
Maione, P.3
-
3
-
-
0035379611
-
The emerging genetic and molecular basis of Fanconi anaemia
-
Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2001; 2:446-457.
-
(2001)
Nat. Rev. Genet.
, vol.2
, pp. 446-457
-
-
Joenje, H.1
Patel, K.J.2
-
5
-
-
0035105291
-
Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
-
Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001; 7:249-262.
-
(2001)
Mol. Cell.
, vol.7
, pp. 249-262
-
-
Garcia-Higuera, I.1
Taniguchi, T.2
Ganesan, S.3
-
6
-
-
0038075462
-
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors
-
Taniguchi T, Tischkowitz M, Ameziane N, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 2003; 9:568-574.
-
(2003)
Nat. Med.
, vol.9
, pp. 568-574
-
-
Taniguchi, T.1
Tischkowitz, M.2
Ameziane, N.3
-
7
-
-
2342633174
-
Promoter hypermethylation of FANCF: Disruption of Fanconi Anemia-BRCA pathway in cervical cancer
-
Narayan G, Arias-Pulido H, Nandula SV, et al. Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res 2004; 64:2994-2997.
-
(2004)
Cancer Res.
, vol.64
, pp. 2994-2997
-
-
Narayan, G.1
Arias-Pulido, H.2
Nandula, S.V.3
-
8
-
-
0242298162
-
Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia
-
Tischkowitz M, Ameziane N, Waisfisz Q, et al. Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia Br J Haematol 2003; 123:469-471.
-
(2003)
Br. J. Haematol.
, vol.123
, pp. 469-471
-
-
Tischkowitz, M.1
Ameziane, N.2
Waisfisz, Q.3
-
9
-
-
1342301467
-
Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: Implications for treatment and survival
-
Marsit CJ, Liu M, Nelson HH, et al. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 2004; 23:1000-1004.
-
(2004)
Oncogene
, vol.23
, pp. 1000-1004
-
-
Marsit, C.J.1
Liu, M.2
Nelson, H.H.3
-
10
-
-
0141892164
-
FANCD2 protein is expressed in proliferating cells of human tissues that are cancer-prone in Fanconi anaemia
-
Holzel M, van Diest PJ, Bier P, et al. FANCD2 protein is expressed in proliferating cells of human tissues that are cancer-prone in Fanconi anaemia. J Pathol 2003; 201:198-203.
-
(2003)
J. Pathol.
, vol.201
, pp. 198-203
-
-
Holzel, M.1
van Diest, P.J.2
Bier, P.3
-
11
-
-
0019365237
-
Reporting results of cancer treatment
-
Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47:207-214.
-
(1981)
Cancer
, vol.47
, pp. 207-214
-
-
Miller, A.B.1
Hoogstraten, B.2
Staquet, M.3
-
12
-
-
0030912190
-
Revisions in the International System for Staging Lung Cancer
-
Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717.
-
(1997)
Chest
, vol.111
, pp. 1710-1717
-
-
Mountain, C.F.1
-
13
-
-
0034954219
-
Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients
-
Ferreira CG, van der Valk P, Span SW, et al. Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. Ann Oncol 2001; 12:799-805.
-
(2001)
Ann. Oncol.
, vol.12
, pp. 799-805
-
-
Ferreira, C.G.1
van der Valk, P.2
Span, S.W.3
-
14
-
-
0028179558
-
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors
-
Altman DG, Lausen B, Sauerbrei W, et al. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994; 86:829-835.
-
(1994)
J. Natl. Cancer Inst.
, vol.86
, pp. 829-835
-
-
Altman, D.G.1
Lausen, B.2
Sauerbrei, W.3
-
15
-
-
0037306904
-
Cancer incidence in persons with Fanconi anemia
-
Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101:822-826.
-
(2003)
Blood
, vol.101
, pp. 822-826
-
-
Rosenberg, P.S.1
Greene, M.H.2
Alter, B.P.3
-
16
-
-
0037441757
-
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
-
Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003; 101:1249-1256.
-
(2003)
Blood
, vol.101
, pp. 1249-1256
-
-
Kutler, D.I.1
Singh, B.2
Satagopan, J.3
-
17
-
-
0037439356
-
Cancer in Fanconi anemia, 1927-2001
-
Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003; 97:425-440.
-
(2003)
Cancer
, vol.97
, pp. 425-440
-
-
Alter, B.P.1
-
18
-
-
17744394476
-
Positional cloning of a novel Fanconi anemia gene, FANCD2
-
Timmers C, Taniguchi T, Hejna J, et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell 2001; 7:241-248.
-
(2001)
Mol. Cell.
, vol.7
, pp. 241-248
-
-
Timmers, C.1
Taniguchi, T.2
Hejna, J.3
-
19
-
-
4043083351
-
Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA
-
Ferrer M, De Winter JP, Jeroen Mastenbroek DC, et al. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA. Cancer Gene Ther 2004; 11:539-546.
-
(2004)
Cancer Gene Ther.
, vol.11
, pp. 539-546
-
-
Ferrer, M.1
De Winter, J.P.2
Jeroen Mastenbroek, D.C.3
-
20
-
-
19544379515
-
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
-
Taron M, Rosell R, Felip E, et al. BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer. Hum Mol Genet 2004; 13:2443-2449.
-
(2004)
Hum. Mol. Genet.
, vol.13
, pp. 2443-2449
-
-
Taron, M.1
Rosell, R.2
Felip, E.3
|